NFKB1 and lung carcinoma: Next to MYC, NF-κB signaling is broadly described to be involved in multiple steps of lung carcinogenesis, to mediate therapy resistance [74], and to be active in lymph node metastasis [27], providing an important linkage between the pathogenesis of pulmonary inflammation and lung cancer [75].